Lilly eczema trials open doors to new treatment hope
Eczema remains one of the most common chronic skin conditions, yet its impact is not evenly distributed. For many African American patients, the condition presents differently, lasts longer, and is often underdiagnosed or mismanaged. New clinical research, including trials backed by Eli Lilly and Company, is beginning to address these gaps while expanding access to […]
Is retatrutide more effective than Ozempic for weight loss
Retatrutide still experimental and not yet approved by the U.S. Food and Drug Administration, the medication is already reshaping the way researchers think about weight loss medicine. Here is what experts currently know about it. Now, a newer drug is quietly generating some of the most significant buzz in clinical research. By now, most people […]